News | April 26, 2021
Lonza will invest CHF 200 mn to construct manufacturing complex
New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space
New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space
Presently, IMPCL is manufacturing 656 classical Ayurvedic, 332 Unani and 71 proprietary Ayurvedic medicines for the various diseases spectrum
Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28
Biocon Pharma will be responsible for drug development and manufacturing, while Libbs will leverage its deep expertise and reach in Brazil to import, distribute and market
A mix of favorable government policies and a positive environment will create a win-win situation for all stakeholders
Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.
Subscribe To Our Newsletter & Stay Updated
